From: Burden of lymphoma in China, 2006–2016: an analysis of the Global Burden of Disease Study 2016
Variable | Hodgkin’s lymphoma | Non-Hodgkin’s lymphoma | ||||||
---|---|---|---|---|---|---|---|---|
Trend 1# | Trend 2# | Trend 1# | Trend 2# | |||||
Year | APC | Year | APC | Year | APC | Year | APC | |
Incidence | 2006–2011 | − 0.96* | 2011–2016 | 2.17* | 2006–2013 | 5.19* | 2013–2016 | 3.47* |
Mortality | 2006–2011 | − 5.63* | 2011–2016 | − 3.20* | 2006–2013 | 1.84* | 2013–2016 | − 0.54 |
Prevalence | 2006–2011 | 1.00* | 2011–2016 | 3.92* | 2006–2013 | 6.74* | 2013–2016 | 4.88* |
YLLs | 2006–2012 | − 5.75* | 2012–2016 | − 3.14* | 2006–2013 | 1.60* | 2013–2016 | − 0.78 |
YLDs | 2006–2011 | − 1.01* | 2011–2016 | 2.13* | 2006–2013 | 5.34* | 2013–2016 | 3.73* |
DALYs | 2006–2012 | − 5.66* | 2012–2016 | − 2.98* | 2006–2013 | 1.66* | 2013–2016 | − 0.69 |